Negative regulation of inflammation by SIRT1

被引:281
作者
Xie, Jun [1 ]
Zhang, Xiaoming [2 ]
Zhang, Li [1 ]
机构
[1] Chongqing Med Univ, Dept Pathophysiol, Chongqing 400016, Peoples R China
[2] Hubei Univ Chinese Med, Coll Acupuncture & Orthoped, Wuhan, Peoples R China
关键词
Sirtuin; 1; Inflammation; Histone deacetylase; Acetylation; Post-translational modification; NF-KAPPA-B; PROMOTES CELL-SURVIVAL; TRANSCRIPTIONAL REGULATION; DEACETYLASE ACTIVITY; ACTIVATOR PROTEIN-1; OXIDATIVE STRESS; GENE-EXPRESSION; C-JUN; ALPHA; APOPTOSIS;
D O I
10.1016/j.phrs.2012.10.010
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Sirtuin 1 (SIRT1), the mammalian Sir2 homologue, is a class III histone deacetylase shown to act on a wide range of histones and non-histone substrates. Numerous studies have demonstrated that SIRT1 regulates critical metabolic and physiological processes including senescence, stress resistance, metabolism and apoptosis. Recently, SIRT1 was also found to play an important role in modulating the development and progression of inflammation through deacetylating histones and critical transcription factor such as nuclear factor kappa B (NF-kappa B) and activator protein 1 (AP-1), thus leading to transcriptional repression of various inflammation-related genes. There is increasing evidence that reduction of SIRT1 levels is closely correlated with many inflammatory diseases while pharmacologic activation of SIRT1 would be a promising therapeutic strategy for inflammation-related diseases. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 106 条
[1]
Phosphorylation of HuR by Chk2 regulates SIRT1 expression [J].
Abdelmohsen, Kotb ;
Pullmann, Rudolf, Jr. ;
Lai, Ashish ;
Kim, Hyeon Ho ;
Galban, Stefanie ;
Yang, Xiaoling ;
Blethrow, Justin D. ;
Walker, Mark ;
Shubert, Jonathan ;
Gillespie, David A. ;
Furneaux, Henry ;
Gorospe, Myriam .
MOLECULAR CELL, 2007, 25 (04) :543-557
[2]
Sirtuin inhibitors [J].
Alcain, Francisco J. ;
Villalba, Jose M. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (03) :283-294
[3]
Bacterial lipopolysaccharides and innate immunity [J].
Alexander, C ;
Rietschel, ET .
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (03) :167-202
[4]
The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[5]
Biochemical effects of SIRT1 activators [J].
Baur, Joseph A. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (08) :1626-1634
[6]
The global burden of asthma [J].
Braman, Sidney S. .
CHEST, 2006, 130 (01) :4S-12S
[7]
NF-κB inhibitors for the treatment of inflammatory diseases and cancer [J].
Calzado, Marco A. ;
Bacher, Susanne ;
Schmitz, M. Lienhard .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (03) :367-376
[8]
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling [J].
Cao, Wangsen ;
Bao, Clare ;
Padalko, Elizaveta ;
Lowenstein, Charles J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (06) :1491-1503
[9]
The extracellular release of Schistosoma mansoni HMGB1 nuclear protein is mediated by acetylation [J].
Carneiro, Vitor Coutinho ;
Maciel, Renata de Moraes ;
de Abreu da Silva, Isabel Caetano ;
Madeira da Costa, Rodrigo Furtado ;
Paiva, Claudia Neto ;
Bozza, Marcelo Torres ;
Fantappie, Marcelo Rosado .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (04) :1245-1249
[10]
Tissue-specific regulation of SIRT1 by calorie restriction [J].
Chen, Danica ;
Bruno, Joanne ;
Easlon, Erin ;
Lin, Su-Ju ;
Cheng, Hwei-Ling ;
Alt, Frederick W. ;
Guarente, Leonard .
GENES & DEVELOPMENT, 2008, 22 (13) :1753-1757